2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow H-1337 Placebo: new trials by email Literature Review of H-1337 Placebo trials Research Report on H-1337 Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension H-1337 0.6%, H-1337 1.0%, H-1337 Placebo - Glaucoma Open-Angle Primary, Ocular Hypertension | Phase 2 | Completed | D. Western Therapeutics Institute, Inc. | 201 | 2023-08-28 | 2025-08-27 |
| H-1337 Ophthalmic Solution Phase 1/2 H-1337 Placebo, H-1337 [1], H-1337 [2] - Glaucoma, Open-Angle | Phase 1 / Phase 2 | Completed | Allysta Pharmaceutical | 87 | 2018-03-15 | 2022-07-12 |
Glaucoma, Open-Angle (2) · Glaucoma (1) · Ocular Hypertension (1)
Allysta Pharmaceutical (1) · D. Western Therapeutics Institute, Inc. (1)
United States (2)
El-Roy Dixon, MD (1)